过氧化物酶体增殖物激活受体γ与脓毒症的关系
被引量:2
出处
《中国危重病急救医学》
CAS
CSCD
北大核心
2005年第4期244-246,共3页
Chinese Critical Care Medicine
基金
全军"十五"医药卫生重点科研基金项目(01L003)
参考文献32
-
1Blanquart C,Barbier O,Fruchart J C,et al.Peroxisome proliferator-activated receptors:regulation of transcriptional activities and roles in inflammation [J].J Steroid Biochem Mol Biol,2003,85:267-273.
-
2Youssef J,Badr M.Role of peroxisome proliferator-activated receptors in inflammation control [J].J Biomed Biotechnol,2004,3:156-166.
-
3Zhang X,Young H A.PPAR and immune system-what do we know[J]?Int Immunopharmacol,2002,2:1029-1044.
-
4Fajas L,Auboeuf D,Raspe E,et al.The organization,promoter analysis,and expression of the human PPAR gamma gene [J].J Biol Chem,1997,272:18779-18789.
-
5Desvergne B,Wahli W.Peroxisome pro-liferator-activated receptors:nuclear control of metabolism [J].Endocr Rev,1999,20:649-688.
-
6Ricote M,Li A C,Willson T M,et al.The peroxisome proliferator-activated receptor γ is a negative regulator of macrophage activation [J].Nature,1998,391:79-82.
-
7Kelly D,Campbell J I,King T P,et al.Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPARγ and Rel A [J].Nat Immuunol,2004,5:104-112.
-
8Yang X Y,Wang L H,Chen T,et al.Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptorγ (PPARγ)agonists:PPARγ co-association with transcription factor NFAT [J].J Biol Chem,2000,275:4541-4544.
-
9Okada M,Yan S F,Pinsky D J.Peroxisome proliferator-activated receptor-γ(PPAR-γ) activatin suppresses ischemic induction of Egγ-1 and its in flammatory gene targets[J].FASEB J,2002,16:1861-1868.
-
10Chinetti G,Griglio S,Antonucci M,et al.Activation of proliferator activated receptors alpha and gamma induces apoptosis of human monocyte derived macrophages [J].J Biol Chem,1998,273:25573-25580.
同被引文献34
-
1盛志勇,姚咏明,林洪远.Immunologic dissonance in the pathogenesis of sepsis[J].中国危重病急救医学,2006,18(11):641-642. 被引量:11
-
2邵义明,姚华国,梁小仲,夏炎火.高迁移率族蛋白B1表达水平与大鼠脓毒症严重程度及预后关系的实验研究[J].中国危重病急救医学,2006,18(11):668-672. 被引量:54
-
3Villar J, Maca-Meyer N,Perez-Mendez L,et al. Bench-to-bedside review:understanding genetic predisposition to sepsis. Crit Care, 2004,8:180-189.
-
4Asada K, Sasaki S, Suda T, et al. Antiinflammatory roles of peroxi- some proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med, 2004,169 : 195-200.
-
5Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma,reduces acute inflammation. Eur J Pharmacol, 2004,483 : 79-93.
-
6Siddiqui AM, Cui X,Wu R, et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med, 2006,34:1874-1882.
-
7Wu WT, Lee CC, Lee C J, et al. Rosiglitazone ameliorates endotox- in-induced organ damage in conscious rats. Biol Res Nurs, 2011,13:38-43.
-
8Tsujimura Y, Matsutani T, Matsuda A, et al. Effects of pioglitazone on survival and omental adipocyte function in mice with sepsis induced by cecal ligation and puncture. J Surg Res,2011,171: e215-221.
-
9Chapman KE, Sinclair SE, Zhuang D, et al. Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells [J]. Am J Physiol Lung Cell Mol Physiol, 2005, 289 (5): L834-841. DOI: 10.1152/ajplung.00069.2005.
-
10Papaiahgari S, Yerrapureddy A, Reddy SR, et al. Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice [J]. Am J Respir Crit Care Med, 2007, 176 (12): 1222-1235. DOI: 10.1164/rccm.200701-060OC.
引证文献2
-
1曾勉,黄晓梅,何婉媚,陈虎,蒋玉洁.罗格列酮联合头孢他啶对脓毒症大鼠过氧化物酶体增殖物激活受体γ活性和白细胞介素的影响[J].中国危重病急救医学,2012,24(9):550-553. 被引量:3
-
2钟荣,肖军,戴春光,于志辉,周吉.通过抑制小窝蛋白磷酸化调控Nrf2信号通路可以对呼吸机相关性肺损伤起保护作用[J].中华危重病急救医学,2016,28(6):547-552. 被引量:3
二级引证文献6
-
1张莹,马晓媛,梁华平.抗菌药物在脓毒症中的应用进展[J].中华危重病急救医学,2015,27(9):773-776. 被引量:6
-
2钟荣,肖军,戴春光,于志辉.抑制c-Abl激酶调节桩蛋白酪氨酸磷酸化对通气损伤活体大鼠的保护效应[J].中华危重病急救医学,2017,29(7):596-601. 被引量:2
-
3靳希成,秦海东,孙才智,沈华,张铮.罗格列酮对脓毒症大鼠急性肺损伤保护作用的研究[J].实用老年医学,2017,31(9):816-820. 被引量:3
-
4李荣华,胡秀才,单士强,李永博,崔文斌,刘玲玲.莱菔硫烷预先给药对兔单肺通气时肺损伤Nrf2蛋白变化及抗肺损伤的机制[J].中国老年学杂志,2020,40(17):3756-3759.
-
5张晗硕,梅花,张亚昱.Nrf2为靶点治疗支气管肺发育不良的研究进展[J].实用药物与临床,2021,24(8):747-751. 被引量:1
-
6文晓旭,孟佳,明丹,孙爱慧.罗格列酮对脓毒症肺损伤患者血清炎症水平的影响[J].河北医药,2022,44(4):564-566. 被引量:1
-
1陆静尔,任跃忠.过氧化物酶体增殖物激活受体与胰岛素抵抗的研究进展[J].国外医学(老年医学分册),2006,27(5):222-224. 被引量:4
-
2黄雪梅(综述),王伶(审校),苏海(审校).PPARγ的信号转导途径[J].中国医师杂志,2008,10(3):421-423. 被引量:1
-
3何斌,何庆.PPARγ及配体在肺损伤中的作用[J].西部医学,2007,19(5):956-958. 被引量:4
-
4张维,钱世鹍.过氧化物酶体增殖物激活受体γ及配体对机体免疫调节作用的研究进展[J].广东医学,2014,35(19):3099-3102. 被引量:3
-
5王萌,赵洪礼,马廷行.过氧化物酶体增殖物激活受体-γ与胰腺疾病的关系[J].中国实用医药,2010,5(15):257-260.
-
6涂传涛,张顺财.过氧化物酶体增殖物激活受体γ与肝星状细胞[J].肝脏,2002,7(2):121-123. 被引量:1
-
7马玉梅,霍清萍.基质金属蛋白酶-9与动脉粥样硬化及中医药防治[J].中西医结合心脑血管病杂志,2014,12(9):1127-1129. 被引量:1
-
8陈利群,甘华.PPARs、TZD与肾脏疾病[J].国外医学(泌尿系统分册),2004,24(4):526-528. 被引量:4
-
9刘庆彤,师水生.过氧化物酶体增殖物激活受体γ及其配体与肝纤维化研究进展[J].国际消化病杂志,2007,27(2):137-139. 被引量:3
-
10刘峰,陈楠.过氧化物酶体增殖物激活受体与肾脏病研究新进展[J].中国中西医结合肾病杂志,2005,6(1):51-54. 被引量:3